Page 312 - 73_04

RAFAEL MAYORAL Y COLS. ANAL. REAL ACAD. NAC. FARM.

(80) WIECHEN, K. (2001). Caveolin-1 is down-regulated in human ovarian carci-
(81) noma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:
1635-1643.
(82) WILLIAMS, T. M. (2004) Caveolin-1 gene disruption promotes mammary tu-
(83) morigenesis and dramatically enhances lung metastasis in vivo. Role of
Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secre-
(84) tion. J. Biol. Chem. 279: 51630-51646.
(85) LEE, S. W., REIMER, C. L., OH, P., CAMPBELL, D. B. AND SCHNITZER, J. E. (1998)
(86) Tumor cell growth inhibition by caveolin re-expression in human breast
(87) cancer cells. Oncogene. 16: 1391-1397.
(88) ENGELMAN, J. A., CHU, C., LIN, A., JO, H., IKEZU, T., OKAMOTO, T., KOHTZ, D. S.
(89) AND LISANTI, M. P. (1998) Caveolin-mediated regulation of signaling along
(90) the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding
(91) domain. FEBS Lett. 428: 205-211.
LIU, P., YING, Y., KO, Y. G., AND ANDERSON, R. G. (1996) Localization of
(92) platelet-derived growth factor-stimulated phosphorylation cascade to ca-
veolae. J. Biol. Chem. 271: 10299-10303.
(93) YAMAMOTO, M., TOYA, Y., JENSEN, R. A. AND ISHIKAWA, Y. (1999) Caveolin is an
inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell. Res.
247: 380-388.
ZUNDEL, W., SWIERSZ, L. M. AND GIACCIA, A. (2000) Caveolin 1-mediated regu-
lation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase
activity by ceramide. Mol. Cell. Biol. 20: 1507-1514.
LIU, P. AND ANDERSON, R. G. (1995) Compartmentalized production of cera-
mide at the cell surface. J. Biol. Chem. 270: 27179-27185.
SCHEEL, J., SRINIVASAN, J., HONNERT, U., HENSKE, A. AND KURZCHALIA, T. V.
(1999) Involvement of caveolin-1 in meiotic cell-cycle progression in Cae-
norhabditis elegans. Nat. Cell Biol. 1: 127-129.
HAYASHI, K., MATSUDA, S., MACHIDA, K., YAMAMOTO, T., FUKUDA, Y., NIMURA, Y.,
HAYAKAWA, T. AND HAMAGUCHI, M. (2001) Invasion activating caveolin-1 muta-
tion in human scirrhous breast cancers. Cancer Res. 61: 2361-2364.
CUI, J., ROHR, L. R., SWANSON, G., SPEIGHTS, V. O., MAXWELL, T. AND BROTHMAN,
A. R. (2001) Hypermethylation of the caveolin-1 gene promoter in prostate
cancer. Prostate. 46: 249-256.
HURLSTONE, A. F., REID, G., REEVES, J. R., FRASER, J., STRATHDEE, G., RAHILLY,
M., PARKINSON, E. K. AND BLACK, D. M. (1999) Analysis of the CAVEOLIN-1
gene at human chromosome 7q31.1 in primary tumours and tumour-deri-
ved cell lines. Oncogene. 18: 1881-1890.
DRUMHELLER, T., MCGILLIVRAY, B. C., BEHRNER, D., MACLEOD, P., MCFADDEN, D.
E., ROBERSON, J., VENDITTI, C., CHORNEY, K., CHORNEY, M. AND SMITH, D. I.
(1996) Precise localisation of 3p25 breakpoints in four patients with the 3p-
syndrome. J. Med. Genet. 33: 842-847.
PATLOLLA, J. M., SWAMY, M. V., RAJU, J. AND RAO, C. V. (2004). Overexpression
of caveolin-1 in experimental colon adenocarcinomas and human colon
cancer cell lines. Oncol. Rep. 11: 957-963.

1122